Evaluation of routine functional testing after percutaneous coronary intervention

American Journal of Cardiology

Volumn 93, Issue 6, 2004, Pages 744-747

  Eisenberg, Mark J ^a   Blankenship, James C ^b   Huynh, Thao ^b   Azrin, Michael ^b   Pathan, Asad ^b   Sedlis, Steven ^b   Panja, Manotosh ^b   Starling, Mark R ^b   Beyar, Rafael ^b   Azoulay, Arik ^b   Caron, Joanna ^b   Pilote, Louise ^b  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDURANCE; EXERCISE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREADMILL;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; DIAGNOSTIC TESTS, ROUTINE; EUROPE; EXERCISE TEST; FEMALE; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; QUALITY OF LIFE; QUEBEC; QUESTIONNAIRES; RECOVERY OF FUNCTION; RECURRENCE; TREATMENT OUTCOME; UNITED STATES;

EID: 12144287548     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.11.071     Document Type: Article

References (9)

1. Gibbons R.J., Balady G.J., Beasley J.W., Bricker J.T., Duvernoy W.F., Froelicher V.F., Mark D.B., Marwick T.H., McCallister B.D., Thompson P.D., et al. ACC/AHA guidelines for exercise testing a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee on exercise testing). J Am Coll Cardiol. 30:1997;260-311.
2. Hlatky M.A., Boineau R.E., Higginbotham M.B., Lee K.L., Mark D.B., Califf R.M., Cobb F.R., Pryor D.B. A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index). Am J Cardiol. 64:1989;651-654.
3. Spertus J.A., Winder J.A., Dewhurst T.A., Deyo R.A., Fihn S.D. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol. 74:1994;1240-1244.
4. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health status survey (SF-36). I. Conceptual framework and item selection. Med Care. 30:1992;MS253-MS265.
5. Seto T.B., Taira D.A., Berezin R., Chauhan M.S., Cutlip D.E., Ho K.K., Kuntz R.E., Cohen D.J. Percutaneous coronary revascularization in elderly patients impact on functional status and quality of life. Ann Intern Med. 132:2000;955-958.
6. Pocock S.J., Henderson R.A., Clayton T., Lyman G.H., Chamberlain D.A. Quality of life after coronary angioplasty or continued medical treatment for angina three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina. J Am Coll Cardiol. 35:2000;907-914.
7. Strauss W.E., Fortin T., Hartigan P., Folland E.D., Parisi A.F. A comparison of quality of life scores in patients with angina pectoris after angioplasty compared with after medical therapy. Outcomes of a randomized clinical trial. Veterans Affairs Study of Angioplasty Compared to Medical Therapy Investigators. Circulation. 92:1995;1676-1677.
8. Gidengil C., Garzon P., Eisenberg M.J. Functional testing after percutaneous transluminal coronary angioplasty in Canada and the United States a survey of practice patterns. Can J Cardiol. 16:2000;739-746.
9. Eisenberg M.J., Schechter D., Lefkovits J., Goudreau E., Deligonul U., Mak K.H., Del Core M., Duerr R., Garzon P.M., Huynh T., et al. ROSETTA Investigators. Use of routine functional testing after percutaneous transluminal coronary angioplasty results from the ROSETTA Registry. Am Heart J. 141:2001;837-846.